Allianz shares are trading just shy of their 52-week high at EUR 390, having gained roughly twelve percent year-to-date. This resilience comes despite a challenging macroeconomic backdrop for insurers, setting the stage for a pivotal fortnight of corporate events in May that will shape the investment narrative.
The flurry of activity begins with the Annual General Meeting on May 7th in Munich. Shareholders will vote on a significant overhaul of the executive compensation scheme, which will now tie management bonuses more tightly to the stock’s performance. The key change is a halving of the underperformance threshold: long-term bonuses will be forfeited if the Allianz share price lags the European sector index by more than 25 percentage points over a sustained period, down from the previous 50-point hurdle.
Concurrently, a major refresh of the Supervisory Board is underway. Michael Diekmann is stepping down, with Dr. Jörg Schneider proposed as his successor as chairman. Votes will be cast on a total of three new mandates.
Capital return remains a central theme. The board has proposed a dividend of EUR 17.10 per share, an 11 percent increase from the previous year. This marks the fifth consecutive annual hike and extends a 17-year streak without a cut. To receive the payout, investors must hold the stock before the ex-dividend date on May 8th. Furthermore, a share buyback program running until the end of 2026 continues to withdraw equity from the market. Since its mid-March launch, Allianz has already repurchased approximately 1.14 million of its own shares. The full program is authorized to buy back up to EUR 2.5 billion in stock, a move that mechanically boosts earnings per share for remaining investors.
Should investors sell immediately? Or is it worth buying Allianz?
Just days after the dividend decision, on May 13th, the company will release its first-quarter 2026 results. These figures will provide the first hard data on whether Allianz is on track to meet its full-year target of roughly EUR 17.4 billion in operating profit, with a guided range of EUR 16.4 to 18.4 billion.
This earnings report takes on added significance given recent warnings from the group’s own credit insurance subsidiary, Allianz Trade. The unit cautions that geopolitical tensions and a rise in protectionism are fueling a global wave of insolvencies. It forecasts that payment defaults in 2026 will remain about 24 percent above pre-pandemic levels. Rising corporate failures translate directly into higher claims for this core business segment, presenting a tangible headwind.
From a technical perspective, the stock has advanced nearly ten percent over the past 30 days. Its next key resistance level is the 52-week high of EUR 392.50, with the Relative Strength Index (RSI) at 41.6 indicating the uptrend is not yet in overbought territory.
The condensed May schedule delivers a cluster of critical data points: a revamped pay policy, a refreshed board, a record dividend, and the first quarterly health check of the year. For shareholders, the outcome will paint a much clearer picture of Allianz’s ability to sustain its generous capital returns while navigating an increasingly precarious economic landscape.
Ad
Allianz Stock: Buy or Sell?! New Allianz Analysis from April 19 delivers the answer:
The latest Allianz figures speak for themselves: Urgent action needed for Allianz investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from April 19.
Allianz: Buy or sell? Read more here...
